Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Kim, Miyoung ^a,b   Hwang, Seungwoo ^c   Park, Kiejung ^c   Kim, Seon Young ^b   Lee, Young Kyung ^a   Lee, Dong Soon ^b  

^a Hallym University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DNA DIRECTED RNA POLYMERASE; DNA DIRECTED RNA POLYMERASE III; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; IMMUNOPHENOTYPING; INTERFERON ALPHA GENE; INTERFERON BETA GENE; INTERFERON SIGNALING GENE; ISG15 GENE; MALE; MESENCHYMAL STROMA CELL; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; MYELODYSPLASTIC SYNDROME; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR MICROENVIRONMENT;

ADULT; AGED; BONE MARROW CELLS; CELLULAR MICROENVIRONMENT; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERFERONS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 84925834865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120602     Document Type: Article

References (59)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, 2008 IARC Press, Lyon.
2. Tefferi A, Vardiman JW. Myelodysplastic Syndromes. N Engl J Med 2009; 361:1872-1885 doi: 10. 1056/NEJMra0902908 PMID: 19890130
3. Bernasconi P. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review. Br J Haematol. 2008 Sep; 142(5):695-708. doi: 10.1111/j.1365-2141.2008.07245.x PMID: 18540941
4. Nishino HT, Chang CC. Myelodysplastic syndromes: clinicopathologic features, pathobiology, and molecular pathogenesis. Arch Pathol Lab Med. 2005 Oct; 129(10):1299-310. PMID: 16196520
5. Graubert T, Walter MJ. Genetics of myelodysplastic syndromes: new insights. Hematology Am Soc Hematol Educ Program. 2011; 2011:543-9. doi: 10.1182/asheducation-2011.1.543 PMID: 22160087
6. Hirai H. Molecular mechanisms of myelodysplastic syndrome. Jpn J Clin Oncol. 2003 Apr; 33(4):153-60. PMID: 12810828
7. Padua RA, Guinn BA, Al-Sabah AI, Smith M, Taylor C, Pettersson T, et al. RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia. 1998 Jun; 12 (6):887-92. PMID: 9639416
8. Misawa S, Horiike S, Kaneko H, Kashima K. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome. Leukemia. 1997 Apr; 11 Suppl 3:533-5. PMID: 9209448
9. Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, Bertini M, et al. Piedmont Study Group on Myleodysplastic Syndromes. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. J Clin Oncol. 003 May 15; 21(10):1988-95. PMID: 12743153
10. Kim M, Oh B, Kim SY, Park HK, Hwang SM, Kim TY, et al. p15INK4b methylation correlates with thrombocytopenia, blast percentage, and survival in myelodysplastic syndromes in a dose dependent manner: quantitation using pyrosequencing study. Leuk Res. 2010 Jun; 34(6):718-22. doi: 10.1016/j. leukres.2009.09.007 PMID: 19782398
11. Borojevic R, Roela RA, Rodarte RS, Thiago LS, Pasini FS, Conti FM, et al. Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression. Leuk Res. 2004 Aug; 28(8):831-44. PMID: 15203281
12. Flores-Figueroa E, Gutiérrez-Espíndola G, Montesinos JJ, Arana-Trejo RM, Mayani H. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk Res. 2002 Jul; 26(7):677-86. PMID: 12008086
13. Raaijmakers MH. Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis. Int J Hematol. 2012 Jan; 95(1):17-25. doi: 10.1007/s12185-011-1001-x PMID: 22218882
14. Dührsen U, Hossfeld DK. Stromal abnormalities in neoplastic bone marrow diseases. Ann Hematol. 1996 Aug; 73(2):53-70. PMID: 8774614
15. Tauro S, Hepburn MD, Peddie CM, Bowen DT, Pippard MJ. Functional disturbance of marrow mesenchymal microenvironment in the myelodysplastic syndromes. Leukemia. 2002 May; 16(5):785-90. PMID: 11986938
16. Aizawa S, Nakano M, Iwase O, Yaguchi M, Hiramoto M, Hoshi H, et al. Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro. Leuk Res. 1999 Mar; 23(3):239-46. PMID: 10071075
17. Tauro S, Hepburn MD, Bowen DT, Pippard MJ. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes. Haematologica. 2001 Oct; 86(10):1038-45. PMID: 11602409
18. Roela RA, Carraro DM, Brentani HP, Kaiano JH, Simão DF, Guarnieiro R, et al. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes. Leuk Res. 2007 May; 31 (5):579-89. PMID: 17092558
19. Van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003 Dec; 17(12):2257-317. PMID: 14671650
20. Langerak AW, Groenen PJ, Brüggemann M, Beldjord K, Bellan C, Bonello L, et al. EuroClonality/ BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia. 2012 Oct; 26(10):2159-71. doi: 10.1038/leu.2012.246 PMID: 22918122
21. Sandberg Y, van Gastel-Mol EJ, Verhaaf B, Lam KH, van Dongen JJ, Langerak AW. BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics. J Mol Diagn. 2005 Oct; 7(4):495-503. PMID: 16237219
22. Klaus M, Stavroulaki E, Kastrinaki MC, Fragioudaki P, Giannikou K, Psyllaki M, et al. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes. Stem Cells Dev. 2010 Jul; 19(7):1043-54. doi: 10.1089/scd. 2009.0286 PMID: 19788374
23. Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007 Nov; 262(5):509-25. PMID: 17949362
24. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008; 24 (13):1547-8. doi: 10.1093/bioinformatics/btn224 PMID: 18467348
25. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011 Feb 1; 27(3):431-2. doi: 10.1093/bioinformatics/btq675 PMID: 21149340
26. Warsow G, Greber B, Falk SS, Harder C, Siatkowski M, Schordan S, Som A, Endlich N, Schöler H, Repsilber D, Endlich K, Fuellen G. ExprEssence-revealing the essence of differential experimental data in the context of an interaction/regulation net-work. BMC Syst Biol. 2010 Nov 30; 4:164. doi: 10. 1186/1752-0509-4-164 PMID: 21118483
27. Lottaz C, Yang X, Scheid S, Spang R. OrderedList-a bioconductor package for detecting similarity in ordered gene lists. Bioinformatics. 2006 Sep 15; 22(18):2315-6. PMID: 16844712
28. Servant N, Gravier E, Gestraud P, Laurent C, Paccard C, Biton A, et al. EMA-A R package for Easy Microarray data analysis. BMC Res Notes. 2010 Nov 3; 3:277. doi: 10.1186/1756-0500-3-277 PMID: 21047405
29. Xie C, Mao X, Huang J, Ding Y, Wu J, Dong S, et al. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res. 2011; 39(Web Server issue):W316-22. doi: 10.1093/nar/gkr483 PMID: 21715386
30. Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 2014 Jan; 42(Database issue):D472-7. doi: 10.1093/nar/gkt1102 PMID: 24243840
31. Kiełbasa SM, Klein H, Roider HG, Vingron M, Blüthgen N. TransFind-predicting transcriptional regulators for gene sets. Nucleic Acids Res. 2010 Jul; 38(Web Server issue):W275-80. doi: 10.1093/nar/ gkq438 PMID: 20511592
32. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 2004 Nov 18; 432(7015):332-7. PMID: 15549095
33. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol. 2006; 1:119-50. PMID: 18039110
34. Feng X, Scheinberg P, Wu CO, Samsel L, Nunez O, Prince C, et al. Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica. 2011 Apr; 96(4):602-6. doi: 10.3324/haematol.2010.030536 PMID: 21160069
35. Suárez-Fariñas M, Noggle S, Heke M, Hemmati-Brivanlou A, Magnasco MO. Comparing independent microarray studies: the case of human embryonic stem cells. BMC Genomics. 2005 Jul 22; 6:99. PMID: 16042783
36. Nelson N, Marks MS, Driggers PH, Ozato K. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol. 1993 Jan; 13(1):588-99. PMID: 7678054
37. Ozato K, Tailor P, Kubota T. The interferon regulatory factor family in host defense: mechanism of action. J Biol Chem. 2007 Jul 13; 282(28):20065-9. Epub 2007 May 14. PMID: 17502370
38. Contursi C, Wang IM, Gabriele L, Gadina M, O'Shea J, Morse HC 3rd, et al. IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages. Proc Natl Acad Sci U S A. 2000 Jan 4; 97(1):91-6. PMID: 10618376
39. Bovolenta C, Driggers PH, Marks MS, Medin JA, Politis AD, Vogel SN, et al. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci U S A. 1994 May 24; 91(11):5046-50. PMID: 8197182
40. Barrett AJ, Sloand E. Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance. Haematologica. 2009 Apr; 94(4):449-51. doi: 10.3324/haematol.2009. 006080 PMID: 19336747
41. Warlick ED, Miller JS. Myelodysplastic syndromes: the role of the immune system in pathogenesis. Leuk Lymphoma. 2011 Nov; 52(11):2045-9. doi: 10.3109/10428194.2011.584002 PMID: 21663505
42. Felli N, Pedini F, Zeuner A, Petrucci E, Testa U, Conticello C, et al. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis. J Immunol. 2005 Aug 1; 175 (3):1464-72. PMID: 16034083
43. Ferrer RA, Wobus M, List C, Wehner R, Schönefeldt C, Brocard B, et al. Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide. Haematologica. 2013 Nov; 98(11):1677-85. doi: 10.3324/haematol.2013.083972 PMID: 23716561
44. Pellagatti A, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG, et al. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia. 2010 Apr; 24 (4):756-64. doi: 10.1038/leu.2010.31 PMID: 20220779
45. Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013 Nov 21; 122(22):3616-27 doi: 10.1182/blood-2013-08-518886 PMID: 24030381
46. Abdel-Wahab O, Figueroa ME. Interpreting new molecular genetics in myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2012; 2012:56-64. doi: 10.1182/asheducation-2012.1.56 PMID: 23233561
47. Brosseau JP, Lucier JF, Nwilati H, Thibault P, Garneau D, Gendron D, et al. Tumor microenvironmentassociated modifications of alternative splicing. RNA. 2014 Feb; 20(2):189-201. doi: 10.1261/rna. 042168.113 PMID: 24335142
48. D'Incalci M, Badri N, Galmarini CM, Allavena P. Trabectedin, a drug acting on both cancer cells and the tumour microenvironment. Br J Cancer. 2014 Aug 12; 111(4):646-50. doi: 10.1038/bjc.2014.149 PMID: 24755886
49. Gattermann N. From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes. Leuk Res. 2000 Feb; 24(2):141-51. PMID: 10654450
50. Schildgen V, Wulfert M, Gattermann N. Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes. Exp Hematol. 2011 Jun; 39(6):666-675. doi: 10.1016/j.exphem.2011.03.007 PMID: 21447369
51. Sun H, Taneja R. Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Proc Natl Acad Sci U S A. 2000 Apr 11; 97(8):4058-63. PMID: 10737769
52. Hughes M, Dobric N, Scott IC, Su L, Starovic M, St-Pierre B, et al. The Hand1, Stra13 and Gcm1 transcription factors override FGF signaling to promote terminal differentiation of trophoblast stem cells. Dev Biol. 2004 Jul 1; 271(1):26-37. PMID: 15196947
53. Zheng Y, Jia Y, Wang Y, Wang M, Li B, Shi X, et al. The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer. OMICS. 2009 Aug; 13(4):301-6. doi: 10.1089/ omi.2009.0014 PMID: 19624270
54. Chakrabarti J, Turley H, Campo L, Han C, Harris AL, Gatter KC, et al. The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer. 2004 Aug 31; 91(5):954-8. PMID: 15328513
55. Ismail PM, Lu T, Sawadogo M. Loss of USF transcriptional activity in breast cancer cell lines. Oncogene. 1999 Sep 30; 18(40):5582-91. PMID: 10523835
56. Qyang Y, Luo X, Lu T, Ismail PM, Krylov D, Vinson C, et al. Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol Cell Biol. 1999 Feb; 19(2):1508-17. PMID: 9891084
57. Pawlus MR, Wang L, Ware K, Hu CJ. Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia. Mol Cell Biol. 2012 Nov; 32 (22):4595-610. doi: 10.1128/MCB.00724-12 PMID: 22966206
58. Choi H, Chun YS, Kim SW, Kim MS, Park JW. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol Pharmacol. 2006 Nov; 70(5):1664-71. PMID: 16880289
59. Ivanov SV, Salnikow K, Ivanova AV, Bai L, Lerman MI. Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13. Oncogene. 2007 Feb 8; 26(6):802-12. PMID: 16878149